tiprankstipranks
Immutep Ltd (PRRUF)
OTHER OTC:PRRUF

Immutep Ltd (PRRUF) Income Statement

15 Followers

Immutep Ltd Income Statement

Last quarter (Q4 2023), Immutep Ltd's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Immutep Ltd's net income was AU$―. See Immutep Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
-AU$ 3.51MAU$ 6.76MAU$ 3.97MAU$ 7.49MAU$ 139.78K
Cost of Revenue
------
Gross Profit
-AU$ 3.51MAU$ 845.46KAU$ 312.84K--
Operating Expense
-AU$ 43.96MAU$ 7.21MAU$ 6.28MAU$ 22.56MAU$ 19.10M
Operating Income
-AU$ -40.46MAU$ -6.36MAU$ -5.97MAU$ -15.07MAU$ -18.96M
Net Non Operating Interest Income Expense
-AU$ 918.60KAU$ -32.91MAU$ -30.38MAU$ 189.08KAU$ 397.28K
Other Income Expense
-AU$ 981.18KAU$ 28.22MAU$ 53.42MAU$ 1.41MAU$ 221.15K
Pretax Income
-AU$ -39.90MAU$ -32.21MAU$ -29.90MAU$ -13.47MAU$ -18.34M
Tax Provision
--AU$ 34.00AU$ 33.00AU$ 37.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -39.90MAU$ -98.48MAU$ -90.29MAU$ -13.47MAU$ -18.34M
Basic EPS
-AU$ -0.04AU$ -0.04AU$ -0.05AU$ -0.03AU$ -0.06
Diluted EPS
-AU$ -0.04AU$ -0.04AU$ -0.05AU$ -0.03AU$ -0.06
Basic Average Shares
-AU$ 892.40MAU$ 2.46BAU$ 1.81BAU$ 412.86MAU$ 324.76M
Diluted Average Shares
-AU$ 892.40MAU$ 2.46BAU$ 1.81BAU$ 412.86MAU$ 324.76M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-AU$ 43.96MAU$ 7.21MAU$ 6.28MAU$ 22.56MAU$ 19.10M
Net Income From Continuing And Discontinued Operation
-AU$ -39.90MAU$ -98.48MAU$ -90.29MAU$ -13.47MAU$ -18.34M
Normalized Income
----AU$ -15.26MAU$ -19.80M
Interest Expense
----AU$ 10.46KAU$ 0.00
EBIT
--AU$ -32.21MAU$ -29.92MAU$ -13.46MAU$ -18.34M
EBITDA
--AU$ -32.21MAU$ -31.99MAU$ -13.46MAU$ -16.46M
Currency in AUD

Immutep Ltd Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis